Sat, Dec 27, 2014, 8:08 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.


you are viewing a single comment's thread.

view the rest of the posts
  • easyesteemer easyesteemer Nov 26, 2012 12:05 PM Flag

    Current Depressed Share Price Accomodates Accumulation

    Volume and action support your thesis. The real question is when will it end and how much info will be released when that happens. Definitely games being played. Trying to play with them not against them.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The company has enough cash now to run its operations for a few months at least but needs more cash reserve for forthcoming more expensive Phase II-III efficacy trials after the safety trials are satisfactorily over. Therefore, Lincoln Park may continue doing this little by little for several months. Of course, Lincoln Park is in to make money and not loose money. Thus, with the money it's providing to the company, the company may facilitate Lincoln Park's investment at the best price possible while giving it some clues as to where the trial results are headed.

      Unless RS is done and the company enters into Phase II of the trials, other istitutional investors will stay away. I believe, Rabin is counting on big pharmas' attraction after Phhase II ensues. Thus, a lot is likley to happen sometime later in 2013. My point is that this stock currently is not for traders, it's for investors seeking bottom fishing.

      • 1 Reply to mruyog
      • "this stock currently is not for traders, it's for investors seeking bottom fishing."

        Well there's a strategy that has done nothing but produced such staggering losses, to so many, in such a short time. It should be criminal to make that kind of statement, one that implies there should be a bottom to a penny stock with zero revs, seriously bad management, constant dilution to pay everyone, and years away from FDA validation.

6.98+0.18(+2.65%)Nov 13 12:19 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Prothena Corporation plc
NASDAQFri, Dec 26, 2014 4:00 PM EST
TherapeuticsMD, Inc.
AMEXFri, Dec 26, 2014 4:01 PM EST